Pfizer has fended off Nova Nordisk for control of the next-gen weight-loss drug developer Metsera. Meanwhile, Resmed watches ...
Surmodics, Inc. (Nasdaq: SRDX) ("Surmodics" or the "Company"), a leading provider of medical device and in vitro diagnostic ...
Seasoned global pharmaceutical executive, Mr Brent MacGregor, joins Vaxxas Board to accelerate self-administered HD-MAP vaccines for global ...
Regular orange juice consumption reprograms immune-cell gene activity linked to blood pressure, lipid metabolism, and ...
The biochip market size is calculated at USD 14.37 billion in 2025 and is expected to reach around USD 42.15 billion by 2034, ...
By procedure type, the preimplantation genetic testing market is divided by procedure type into preimplantation genetic ...
Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that results from an analysis of 160 real-world patients with ...
This article introduces the field of bioinformatics and its importance as a cornerstone of biological research, as well as ...
Acetylation of lysine residues in the tail domain of histone H3 is well characterized, but lysine residues in the histone globular domain are also acetylated. Histone modifications in globular domain ...
This study provides a valuable genome-centric characterization of microbial communities across deep sediment cores from a Spartina patens salt marsh. The study provides claims on the metabolic ...